Shanghai JMT-Bio Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 4 | |
| Phase 1/2 | 5 | |
| Phase 2 | 5 | |
| Phase 2/3 | 4 | |
| Phase 3 | 11 |
Disease areas by active trials, top 10 of 12
Lung Cancer (9) · Non-Small Cell Lung Cancer (NSCLC) (9) · HER2-Positive Cancer (8) · Breast Cancer (5) · Colorectal Cancer (3) · Gastric Cancer (3) · Head & Neck Cancer (1) · Liver Cancer (1) · Melanoma (1) · Non-Hodgkin Lymphoma (1)
Get alerts when Shanghai JMT-Bio Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.